Targeting the Sensory Disturbance in Autism Spectrum Disorder

Targeting the Sensory Disturbance in Autism Spectrum Disorder: The Effectiveness of Cognitive-behavior Therapy-based Virtual Reality Exposure Program

NCT05157477•National Taiwan University Hospital

View on ClinicalTrials.gov

Summary

This study aims to establish a cognitive-behavior therapy (CBT) based virtual exposure (VR) exposure program to train ASD adults coping with everyday sensory scenarios. Through the practice and training, the ASD participants may learn the strategy to deal with the common sensory scenarios and master the anxiety around the exposure. The anticipatory anxiety and the maladaptive behaviors may be decreased along with the process of desensitization, while the functional impairment related to sensory sensitivity can partly be recovered.

Eligibility

Age

20 - 45 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•young adult aged between 18 and 45 years who had a diagnosis of ASD from a licensed mental health or medical professional based on DSM-5;
•has sensory and social problems as reported by the participant and the caregiver;
•is motivated to participate in the treatment;
•is fluent in Chinese;
•has a full-scale IQ \> 70 on WAIS-IV;
•scored ≧ 26 on the caregiver-reported Autism Spectrum Quotient (AQ), indicating clinical impairment associated with ASD.

Exclusion Criteria

•A history of major mental illness (e.g., bipolar affective disorder, schizophrenia, or psychosis) or neurological diseases;
•visual impairment and/or hearing impairment that would preclude participation in the CBT-based VR exposure program

Locations (1)

National Taiwan University Hospital

Taipei, Taiwan

Key Dates

Start Date

June 17, 2020

Primary Completion Date

December 31, 2023

Completion Date

December 31, 2023

Last Updated

March 3, 2026

Enrollment

ACTUAL participants

Conditions

Autistic Disorders Spectrum

Interventions

CBT-based VR exporsure program

BEHAVIORAL

Studies of Brain and Body Interaction

NCT03672266

Autistic Disorders SpectrumAdhd+8 more

View study

COMPLETEDNA

Transcranial Direct Current Stimulation in Autistic Spectrum Disorder

NCT05311982

Autistic Disorders Spectrum

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 3, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions